CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$14,192,288
-28.8%
884,806
+2.9%
0.00%
-33.3%
Q2 2023$19,938,068
-1.4%
860,141
-1.2%
0.01%0.0%
Q1 2023$20,226,779
+65.8%
870,718
+3.6%
0.01%
+50.0%
Q4 2022$12,197,599
-23.5%
840,634
+0.5%
0.00%
-33.3%
Q3 2022$15,953,000
+7.8%
836,049
+2.6%
0.01%
+20.0%
Q2 2022$14,803,000
-27.5%
814,668
+0.6%
0.01%
-16.7%
Q1 2022$20,415,000
-6.7%
810,121
+2.2%
0.01%0.0%
Q4 2021$21,880,000
-15.3%
792,731
-0.9%
0.01%
-25.0%
Q3 2021$25,830,000
+1.1%
799,894
-4.3%
0.01%0.0%
Q2 2021$25,552,000
+2.3%
835,560
+1.8%
0.01%
-11.1%
Q1 2021$24,984,000
+51.0%
820,478
-2.0%
0.01%
+28.6%
Q4 2020$16,550,000
+58.1%
836,871
+4.2%
0.01%
+40.0%
Q3 2020$10,469,000
+15.5%
802,834
+0.5%
0.01%
+25.0%
Q2 2020$9,061,000
-23.5%
799,005
-3.4%
0.00%
-42.9%
Q1 2020$11,838,000
-41.7%
827,253
+11.0%
0.01%
-36.4%
Q4 2019$20,296,000
-4.4%
745,343
+0.5%
0.01%
-15.4%
Q3 2019$21,235,000
-2.3%
741,702
-5.2%
0.01%0.0%
Q2 2019$21,729,000
-15.8%
782,148
+0.7%
0.01%
-23.5%
Q1 2019$25,797,000
+11.5%
777,007
-2.4%
0.02%
-5.6%
Q4 2018$23,140,000
-35.8%
796,004
+1.5%
0.02%
-25.0%
Q3 2018$36,070,000
+25.8%
784,111
+2.2%
0.02%
+14.3%
Q2 2018$28,682,000
+47.2%
767,508
+16.4%
0.02%
+40.0%
Q1 2018$19,480,000
-14.2%
659,205
-0.2%
0.02%
-16.7%
Q4 2017$22,693,000
-0.6%
660,729
+4.7%
0.02%
-10.0%
Q3 2017$22,828,000
+28.1%
630,932
-8.5%
0.02%
+17.6%
Q2 2017$17,814,000
+32.8%
689,367
-1.3%
0.02%
+30.8%
Q1 2017$13,411,000
+20.2%
698,450
+4.4%
0.01%
+8.3%
Q4 2016$11,154,000
-4.3%
669,102
+18.1%
0.01%
-14.3%
Q3 2016$11,659,000
-30.3%
566,509
+3.6%
0.01%
-33.3%
Q2 2016$16,726,000
-8.0%
546,578
+12.5%
0.02%
-12.5%
Q1 2016$18,186,000
-6.0%
485,855
+8.4%
0.02%
-7.7%
Q4 2015$19,344,000
+71.7%
448,192
+49.1%
0.03%
+52.9%
Q3 2015$11,267,000
+28.3%
300,599
+16.4%
0.02%
+41.7%
Q2 2015$8,782,000
+76.3%
258,352
+83.6%
0.01%
+71.4%
Q1 2015$4,982,000
-15.6%
140,708
-18.8%
0.01%
-22.2%
Q4 2014$5,905,000
-28.0%
173,367
-18.5%
0.01%
-35.7%
Q3 2014$8,207,000
+1.2%
212,772
+2.1%
0.01%0.0%
Q2 2014$8,111,000
+25.9%
208,393
+10.6%
0.01%
+16.7%
Q1 2014$6,443,000
+106.6%
188,441
+26.8%
0.01%
+100.0%
Q4 2013$3,119,000
+8.6%
148,634
+31.0%
0.01%0.0%
Q3 2013$2,873,000
+3.3%
113,485
+11.5%
0.01%0.0%
Q2 2013$2,781,000101,7920.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders